GW’s Y. Tony Yang received $1 million for an initiative to connect minority communities with culturally relevant vaccination information and resources.
Disenfranchised, minority neighborhoods still exposed to disproportionately high levels of health harming nitrogen dioxide.
GW’s COVID-19 Recovery Clinic works to put patients on the path toward normal.
A SEAS professor used systems engineering principles to discover how a Maryland COVID-19 testing site could deliver quicker results.
GW researchers found that aspirin may have lung-protective effects and reduce in-hospital mortality in hospitalized COVID-19 patients.
CCAS anthropology researchers teamed with a Washington, D.C., artist to digitize a popular COVID-19 memorial.
GW experts discussed the various COVID-19 vaccines approved for emergency use and how to chip away at vaccine hesitancy among your friends and family.
GW will be a clinical trial site for Sanofi and GSK’s adjuvanted recombinant protein-based COVID-19 vaccine candidate.
Public health students document adherence to mask wearing and physical distancing guidelines in their communities.
In a pair of research initiatives, Sociology professor Antwan Jones is shining a spotlight on the pandemic’s impact on psychological health and housing inequalities.
The COVID-19 Research Fund is helping launch research projects to study COVID-19 across various disciplines.
The university served as a clinical trial site for the mRNA vaccine developed by NIH and Moderna, Inc., helping ensure the vaccine was safe and effective for a diverse population.
Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said during an exchange with students at the George Washington University School of Medicine and Health Science
Ethan Porter will study reactions to misinformation in 10 countries with the goal of reducing false beliefs around vaccination.